ARCHIVES

Experts Claim Errors in Breast Cancer Study, Demand Retraction of Practice-Changing Paper

This article is from The Cancer Letter archive.

Vol. 38 No. 20 | May 18, 2012

Download PDF Visit The Full Archive

Related Articles

Insurers Increasingly Willing To Cover ABMT For Breast Cancer, GAO Finds

June 7, 1996

OMB Specifies One Year Only Funding for 200 grants Under Supplemental Appropriations Level of 6,200

September 6, 1985

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977

In Brief: NBCC Honors D’Amato, Leahy, Mack, Stevens; Center Development Officers Elect Leaders

May 8, 1998

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012